Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Various xenobiotic drugs and toxins in the gastrointestinal lumen represent a broad and heterogeneous category of exogenous substances that are the focus of gastrointestinal decontamination and sequestration therapies. These substances include ingested poisons, pharmaceutical overdoses, environmental pollutants, and metabolic byproducts that undergo enterohepatic circulation (StatPearls, NBK482294). Unlike traditional drug targets such as receptors or enzymes, these molecules are targeted by non-absorbable agents like activated charcoal or ion-exchange resins that act through physical adsorption or chemical binding (PubMed, 28595740). The primary clinical objective in targeting these substances is to limit their bioavailability and enhance their fecal excretion, thereby preventing or reducing systemic toxicity (NIH, LiverTox). This approach is a cornerstone in the emergency management of acute poisoning and the chronic management of conditions like hyperphosphatemia or hypercholesterolemia (StatPearls, NBK548315). Because this category encompasses a vast array of chemical structures, the interaction is typically physical or electrochemical rather than site-specific.
Physical adsorption, chemical sequestration, and ion exchange within the gastrointestinal lumen to prevent systemic absorption.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Various xenobiotic drugs and toxins in the gastrointestinal lumen.